Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice

<p>Abstract</p> <p>Background</p> <p>Pancreatic cancer is one of the most aggressive human malignancies, with a very poor prognosis. To evaluate the effect of angiotensin II (Ang II) type 2 receptor (AT<sub>2</sub>) expression in the host's body on the...

Full description

Bibliographic Details
Main Authors: Troyer Deryl, Isayama Yuka, Pickel Lara, Ayuzawa Rie, Uppalapati Deepthi, Ohta Naomi, Maurya Dharmendra, Kawabata Atsushi, Egashira Noboru, Doi Chiyo, Takekoshi Susumu, Tamura Masaaki
Format: Article
Language:English
Published: BMC 2010-02-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/10/67
id doaj-57061e324f6f4e00a5520cbb5995b881
record_format Article
spelling doaj-57061e324f6f4e00a5520cbb5995b8812020-11-25T01:39:17ZengBMCBMC Cancer1471-24072010-02-011016710.1186/1471-2407-10-67Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic miceTroyer DerylIsayama YukaPickel LaraAyuzawa RieUppalapati DeepthiOhta NaomiMaurya DharmendraKawabata AtsushiEgashira NoboruDoi ChiyoTakekoshi SusumuTamura Masaaki<p>Abstract</p> <p>Background</p> <p>Pancreatic cancer is one of the most aggressive human malignancies, with a very poor prognosis. To evaluate the effect of angiotensin II (Ang II) type 2 receptor (AT<sub>2</sub>) expression in the host's body on the growth of pancreatic carcinoma, we have investigated the growth of mouse pancreatic ductal carcinoma grafts in syngeneic wild type and AT<sub>2 </sub>receptor-deficient (AT<sub>2</sub>-KO) mice.</p> <p>Methods</p> <p>The role of AT<sub>2 </sub>receptor-signaling in stromal cells on the growth of murine pancreatic carcinoma cells (PAN02) was studied using various <it>in vitro </it>and <it>in vivo </it>assays. <it>In vivo </it>cell proliferation, apoptosis, and vasculature in tumors were monitored by Ki-67 immunostaining, TUNEL assay, and von Willebrand factor immunostaining, respectively. In the co-culture study, cell proliferation was measured by MTT cell viability assay. All the data were analyzed using t-test and data were treated as significant when <it>p </it>< 0.05.</p> <p>Results</p> <p>Our results show that the growth of subcutaneously transplanted syngeneic xenografts of PAN02 cells, mouse pancreatic ductal carcinoma cells derived from the C57/BL6 strain, was significantly faster in AT<sub>2</sub>-KO mice compared to control wild type mice. Immunohistochemical analysis of tumor tissue revealed significantly more Ki-67 positive cells in xenografts grown in AT<sub>2</sub>-KO mice than in wild type mice. The index of apoptosis is slightly higher in wild type mice than in AT<sub>2</sub>-KO mice as evaluated by TUNEL assay. Tumor vasculature number was significantly higher in AT<sub>2</sub>-KO mice than in wild type mice. <it>In vitro </it>co-culture studies revealed that the growth of PAN02 cells was significantly decreased when grown with AT<sub>2 </sub>receptor gene transfected wild type and AT<sub>2</sub>-KO mouse-derived fibroblasts. Faster tumor growth in AT<sub>2</sub>-KO mice may be associated with higher VEGF production in stromal cells.</p> <p>Conclusions</p> <p>These results suggest that Ang II regulates the growth of pancreatic carcinoma cells through modulating functions of host stromal cells; Moreover, Ang II AT<sub>2 </sub>receptor signaling is a negative regulator in the growth of pancreatic carcinoma cells. These findings indicate that the AT<sub>2 </sub>receptor in stromal fibroblasts is a potentially important target for chemotherapy for pancreatic cancer.</p> http://www.biomedcentral.com/1471-2407/10/67
collection DOAJ
language English
format Article
sources DOAJ
author Troyer Deryl
Isayama Yuka
Pickel Lara
Ayuzawa Rie
Uppalapati Deepthi
Ohta Naomi
Maurya Dharmendra
Kawabata Atsushi
Egashira Noboru
Doi Chiyo
Takekoshi Susumu
Tamura Masaaki
spellingShingle Troyer Deryl
Isayama Yuka
Pickel Lara
Ayuzawa Rie
Uppalapati Deepthi
Ohta Naomi
Maurya Dharmendra
Kawabata Atsushi
Egashira Noboru
Doi Chiyo
Takekoshi Susumu
Tamura Masaaki
Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice
BMC Cancer
author_facet Troyer Deryl
Isayama Yuka
Pickel Lara
Ayuzawa Rie
Uppalapati Deepthi
Ohta Naomi
Maurya Dharmendra
Kawabata Atsushi
Egashira Noboru
Doi Chiyo
Takekoshi Susumu
Tamura Masaaki
author_sort Troyer Deryl
title Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice
title_short Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice
title_full Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice
title_fullStr Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice
title_full_unstemmed Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice
title_sort angiotensin ii type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice
publisher BMC
series BMC Cancer
issn 1471-2407
publishDate 2010-02-01
description <p>Abstract</p> <p>Background</p> <p>Pancreatic cancer is one of the most aggressive human malignancies, with a very poor prognosis. To evaluate the effect of angiotensin II (Ang II) type 2 receptor (AT<sub>2</sub>) expression in the host's body on the growth of pancreatic carcinoma, we have investigated the growth of mouse pancreatic ductal carcinoma grafts in syngeneic wild type and AT<sub>2 </sub>receptor-deficient (AT<sub>2</sub>-KO) mice.</p> <p>Methods</p> <p>The role of AT<sub>2 </sub>receptor-signaling in stromal cells on the growth of murine pancreatic carcinoma cells (PAN02) was studied using various <it>in vitro </it>and <it>in vivo </it>assays. <it>In vivo </it>cell proliferation, apoptosis, and vasculature in tumors were monitored by Ki-67 immunostaining, TUNEL assay, and von Willebrand factor immunostaining, respectively. In the co-culture study, cell proliferation was measured by MTT cell viability assay. All the data were analyzed using t-test and data were treated as significant when <it>p </it>< 0.05.</p> <p>Results</p> <p>Our results show that the growth of subcutaneously transplanted syngeneic xenografts of PAN02 cells, mouse pancreatic ductal carcinoma cells derived from the C57/BL6 strain, was significantly faster in AT<sub>2</sub>-KO mice compared to control wild type mice. Immunohistochemical analysis of tumor tissue revealed significantly more Ki-67 positive cells in xenografts grown in AT<sub>2</sub>-KO mice than in wild type mice. The index of apoptosis is slightly higher in wild type mice than in AT<sub>2</sub>-KO mice as evaluated by TUNEL assay. Tumor vasculature number was significantly higher in AT<sub>2</sub>-KO mice than in wild type mice. <it>In vitro </it>co-culture studies revealed that the growth of PAN02 cells was significantly decreased when grown with AT<sub>2 </sub>receptor gene transfected wild type and AT<sub>2</sub>-KO mouse-derived fibroblasts. Faster tumor growth in AT<sub>2</sub>-KO mice may be associated with higher VEGF production in stromal cells.</p> <p>Conclusions</p> <p>These results suggest that Ang II regulates the growth of pancreatic carcinoma cells through modulating functions of host stromal cells; Moreover, Ang II AT<sub>2 </sub>receptor signaling is a negative regulator in the growth of pancreatic carcinoma cells. These findings indicate that the AT<sub>2 </sub>receptor in stromal fibroblasts is a potentially important target for chemotherapy for pancreatic cancer.</p>
url http://www.biomedcentral.com/1471-2407/10/67
work_keys_str_mv AT troyerderyl angiotensiniitype2receptorsignalingsignificantlyattenuatesgrowthofmurinepancreaticcarcinomagraftsinsyngeneicmice
AT isayamayuka angiotensiniitype2receptorsignalingsignificantlyattenuatesgrowthofmurinepancreaticcarcinomagraftsinsyngeneicmice
AT pickellara angiotensiniitype2receptorsignalingsignificantlyattenuatesgrowthofmurinepancreaticcarcinomagraftsinsyngeneicmice
AT ayuzawarie angiotensiniitype2receptorsignalingsignificantlyattenuatesgrowthofmurinepancreaticcarcinomagraftsinsyngeneicmice
AT uppalapatideepthi angiotensiniitype2receptorsignalingsignificantlyattenuatesgrowthofmurinepancreaticcarcinomagraftsinsyngeneicmice
AT ohtanaomi angiotensiniitype2receptorsignalingsignificantlyattenuatesgrowthofmurinepancreaticcarcinomagraftsinsyngeneicmice
AT mauryadharmendra angiotensiniitype2receptorsignalingsignificantlyattenuatesgrowthofmurinepancreaticcarcinomagraftsinsyngeneicmice
AT kawabataatsushi angiotensiniitype2receptorsignalingsignificantlyattenuatesgrowthofmurinepancreaticcarcinomagraftsinsyngeneicmice
AT egashiranoboru angiotensiniitype2receptorsignalingsignificantlyattenuatesgrowthofmurinepancreaticcarcinomagraftsinsyngeneicmice
AT doichiyo angiotensiniitype2receptorsignalingsignificantlyattenuatesgrowthofmurinepancreaticcarcinomagraftsinsyngeneicmice
AT takekoshisusumu angiotensiniitype2receptorsignalingsignificantlyattenuatesgrowthofmurinepancreaticcarcinomagraftsinsyngeneicmice
AT tamuramasaaki angiotensiniitype2receptorsignalingsignificantlyattenuatesgrowthofmurinepancreaticcarcinomagraftsinsyngeneicmice
_version_ 1725049411195633664